Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Supelco is a premier provider of analytical products and services, specializing in chromatography, spectroscopy, and chemical standards. Founded in 1966, the company became a global leader in the development of high-quality columns for Gas Chromatography (GC) and High-Performance Liquid Chromatography (HPLC). Today, it operates as a key brand within the Life Science business of Merck KGaA, Darmstadt, Germany (operating as MilliporeSigma in the U.S. and Canada). Its portfolio includes over 10,000 products used by analytical chemists in pharmaceutical, environmental, and food and beverage laboratories worldwide. Supelco is particularly recognized for its innovations in Solid Phase Extraction (SPE) and its extensive range of certified reference materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Supelco.